Controversial diabetes drug Avandia has hit the news again this month as a group of diabetes patients seek compensation from manufacturer GlaxoSmithKline. Hundreds of people with diabetes are seeking compensation for health problems relating to taking Avandia.
The patient group blames the pharmaceutical company for failing to warn patients of the cardiovascular risks posed by the pill. According to one recent lawsuit reported in the news, GSK “knew of these dangerous effects in Avandia from the many trials which they performed and to which they had access and from their own analysis of these studies. But [the company] took no action to adequately warn or remedy the defects, but instead concealed, suppressed and failed to disclose these dangers.”
Prescriptions of Avandia have slumped since a 2007 study was published in the New England Journal of Medicine linking Avandia to a greatly increased risk of heart attack. Many more lawsuits relating to the drug could still be underway.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…